Professor Le Van Tan
Contact information
Research groups
Le Van Tan
Professor of Emerging Infectious Diseases
Emerging Infections
Since 2013 Professor Le Van Tan is a member of the Wellcome Trust Fellows. His Training Fellowship aimed to study molecular epidemiology of Hand, Foot and Mouth Disease in Vietnam and its implication for vaccine development and implementation. Currently, he holds a Wellcome Trust Intermediate Fellowship to study the translational potential of new technologies such as mass spectrometry and next-generation sequencing in patients with brain infections in Vietnam, and an NIH funding support to explore novel cause(s) of sepsis in Southeast Asia. His early work focused on pathogen discovery, which led the to discovery of a novel cyclovirus in 4% of Vietnamese patients with encephalitis.
As an independent investigator, his aim is to develop local and national expertise within Vietnam and the wider region so that ongoing and future emerging infectious disease challenges can be addressed from within the affected regions and communities.
Hand, Foot and Mouth Disease in Vietnam
Vietnamese and global strains of pegivirus
Recent publications
-
Awake prone positioning effectiveness in moderate to severe COVID-19 a randomized controlled trial.
Journal article
Phong NT. et al, (2024), Wellcome Open Research, 9, 543 - 543
-
Correction: Aetiology and Potential Animal Exposure in Central Nervous System Infections in Vietnam
Journal article
Brindle HE. et al, (2024), EcoHealth, 21, 210 - 212
-
In Children, N-Methyl-D-Aspartate Receptor Antibody Encephalitis Incidence Exceeds That of Japanese Encephalitis in Vietnam
Journal article
Huong NHT. et al, (2024), Open Forum Infectious Diseases, 11
-
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam
Journal article
Thanh TT. et al, (2024), International Journal of Infectious Diseases, 147, 107173 - 107173
-
Awake prone positioning effectiveness in moderate to severe COVID-19 a randomized controlled trial.
Journal article
Phong NT. et al, (2024), Wellcome Open Research, 9, 543 - 543